Alphatec commenced commercial release of InVictus, a spinal fixation platform to treat a range of pathologies via MIS, open or hybrid surgical approaches.
Centinel Spine received Investigational Device Exemption approval to initiate a two-level clinical trial with prodisc® C Vivo and prodisc C SK anterior cervical total discs.